We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Boston University and Fraunhofer Create Alliance

By Labmedica staff writers
Posted on 30 Nov 2006
Boston University (BU, Boston, MA, USA) and its College of Engineering are joining Fraunhofer Gesellschaft (Munich, Germany) to create the Boston University-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics. More...
BU and Fraunhofer will jointly fund the five-year, U.S.$5 million alliance, which aims to develop arrays for diagnostic applications.

Andrew Sharon, a BU engineering professor and director of the Fraunhofer Center for Manufacturing and Innovation, said that the alliance will create disposable chips for molecular-level disease diagnosis. The firm will fabricate DNA and peptide arrays and perform translational research with the medical school. An optically guided colon-cancer detection and treatment system is a promising innovation also under consideration for initial support by the alliance.

The alliance seeks to take advantage of the two institutions' respective strengths. Advanced biomedical engineering research being conducted throughout BU's College of Engineering, College of Arts and Sciences, and Medical School, generally proceeds to the laboratory bench level. Fraunhofer hopes to take these innovations and convert them into working medical devices and instruments that can be licensed to existing companies or new, spin-off ventures.

Fraunhofer Gesellschaft is very active in biomedical research. Current activities include array-based diagnostics, medical imaging, surgical micro-tools development, and other novel devices and instrumentation. The Fraunhofer Center for Manufacturing Innovation was established at Boston University in 1994. The center scales up basic research into advanced industrial technologies that meet the needs of client companies both locally and globally.



Related Links:
Boston University
Fraunhofer Gesellschaft

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.